WithdrawnNot Applicable

A Study to Evaluate the Efficacy of Cytal® Burn Matrix in the Management of Partial-Thickness Burns to the Hand

Stopped: Sponsor discretion

0Started 2018-08

Plain-language summary

This is a randomized controlled trial (RCT) aimed at determining if use of Cytal® Burn Matrix in the management of partial-thickness burns to the hand shows improved wound healing times when compared to EZ-Derm Porcine Xenograft.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male and Female, 18 to 75 years of age.
✓. Negative pregnancy test required.
✓. Presence of partial thickness burns to one or both hands.
✓. Thermal burn etiology.

Exclusion criteria

✕. Allergy or hypersensitivity to materials in porcine-based study products or personal preference.
✕. Friction, chemical, or electric burn etiology.
✕. Immunosuppression.
✕. Presence of a local and/or systemic infection.
✕. Received prior treatment to the study site within 60 days of Screening.
✕. Concurrent participation in another clinical trial.

What they're measuring

Time to Complete Wound Healing

Timeframe: 6 months

Trial details

NCT IDNCT03598023

SponsorIntegra LifeSciences Corporation

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2020-07-01

View on ClinicalTrials.gov More Partial Thickness Burn of Hand trials